EHMT2 promotes the pathogenesis of hepatocellular carcinoma by epigenetically silencing APC expression
{{output}}
Background: Hepatocellular carcinoma (HCC), the second leading cause of cancer death worldwide, alone accounts for over half (466,100) of new cancer cases and 422,100 deaths based on the average year incidence rates of 2009 to 20... ...
